Replies to post #4498 on Biotech Values

[DewDiligence]

>> during BPA call toward end of Q+A someone asked about statistical significance of 75 and 300mcg dose. Answer was yes against baseline but not against placebo. Middle dose of 150mcg was quite effective but am curious what you think about this. <<

Yes, I found it troubling that the middle dose works better than both the low and high doses. The overall data package for LibiGel was therefore somewhat disappointing and not fully consistent with the bluster in the prior press release. Is this consistent with your view?

P.S. I am holding my shares but have not bought more.